Stephen Swioklo

Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom.

CellRev is a bioprocessing British technology company that specializes in developing innovative cell expansion technology to continuously grow, detach, and collect adherent cells. The company is based in Newcastle-upon-Tyne, UK and was founded in 2018 by Che John Connon, Leo Cornelis Groenewegen, and Martina Miotto. The company's technology is used to advance lifesaving treatments and develop a new sustainable food system.

Part of BSF Enterprise Plc, 3D Bio-Tissues Ltd. is a bio-tech startup that produces bio-equivalent tissues for clinical and cellular agriculture. Based in Newcastle-upon-Tyne, UK, 3DBT corneas are comparable to human donor corneas and are made from human cells without artificial materials or scaffolds. The British company applies novel bio-inspired manufacturing processes to generate complex structures. The company's proprietary technologies harness the natural regenerative ability of human skin cells, allowing for a quick regeneration of human skin. The company was founded by Che John Connon and Ricardo Gouveia, with Che John Connon serving as the CEO since incorporation. 3D Bio-Tissues was acquired by BSF Enterprise Plc on May 17, 2022 for $2.58 million.

SpectrumX Healthcare Ltd. provides healthcare services. The private company is based in Knutsford, UK. The British company was founded in 2020 by Damien Paul Hancox. Damien Paul Hancox has been the CEO since 2020.

Beckley Canopy Therapeutics Ltd. operates as a biopharmaceutical company. It researches and develops innovative cannabis-based health products. The company was founded on January 19, 2018 and is headquartered in Oxford, the United Kingdom.

Vertual Ltd. is a British UK-based company that specializes in developing virtual reality software for radiation therapy education. The private company offers various solutions for educators, clinicians, and physicists, including Vert, a flight simulator for radiation therapy, and Vert Flex, a software-only solution that allows users to use their own hardware. The company's software features 4D support, interactive machine models, patient models, and plan comparison, among others. Debra Leeves has been the CEO of the company since 2018.

Stroma Biosciences Ltd. is a biopharmaceutical company based in Cambridge, UK. Stroma Biosciences is focused on developing novel anti-stromal therapies to treat cancer by targeting survival signals in the tumour stroma, thereby cutting this important lifeline for cancer cells. The British company's work is focused on mesenchymal stroma cells, which are essential for tumour growth and resistance to cancer therapies. Stroma Biosciences has developed a platform to develop novel first-in-class cancer therapeutics by targeting the stromal compartment. The company has a validated disease-activated platform screening primary tumour samples, and its emerging pipeline includes several stromal targets to treat both solid and haematological malignancies. The company was founded in 2020 by Ingo Ringshausen, Andrew Douglas Moore, and Clive Stanway.

4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom.